Fresenius Kabi
Aparna Dagar, PhD, RAC, currently serves as the Vice President of Regulatory Affairs at Fresenius Kabi since December 2024. Dagar has a long-standing career at Fresenius Kabi, having held various positions from Sr Director to Sr Specialist in Regulatory Affairs from August 2009 to November 2023. Dagar earned a Doctor of Philosophy (PhD) in Biopharmaceutical Sciences from the University of Illinois Chicago and a Bachelor's degree in Pharmacy from Government College of Pharmacy, Bangalore.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.